EDGAR Filing Documents for 0001600132-17-000025

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001600132-17-000025

Filing Date

2017-03-20

Accepted

2017-03-20 16:14:09

Documents

Period of Report

2017-05-04

Effectiveness Date

2017-03-20

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	blphproxymarch2017.htm	DEF 14A	713852
2		blphlogoa09.jpg	GRAPHIC	32979
3		blphproxycard2017page1.jpg	GRAPHIC	688195
4		blphproxycard2017page2.jpg	GRAPHIC	529840
	Complete submission text file	0001600132-17-000025.txt		2436823

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36845 | Film No.: 17701561
SIC: 2834 Pharmaceutical Preparations